Tempus AI introduced a suite of new, transformative capabilities available in Tempus One, the company’s generative AI assistant. Tempus One, initially launched in 2023, provides AI-enabled services for physicians and researchers to support data-driven decision-making and advance drug development.
This latest iteration applies Tempus’ proprietary Large Language Model (LLM) Agent Infrastructure, which adapts LLMs to work on unstructured, multimodal healthcare data. This enhancement aims to improve clinical care and research by deriving insights from previously difficult-to-access unstructured data.
The new generative AI-powered capabilities leverage LLMs to provide deeper insights from unstructured data, which often contains rich patient information. This continuous evolution of Tempus One is designed to address the evolving needs of customers and deploy new generative AI solutions effectively.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.